{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:07:15Z","timestamp":1779228435655,"version":"3.51.4"},"reference-count":128,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,19]],"date-time":"2027-05-19T00:00:00Z","timestamp":1810684800000},"content-version":"am","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23-HL153771-01"],"award-info":[{"award-number":["K23-HL153771-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022914","name":"Claude D. Pepper Older Americans Independence Center, School of Medicine, University of Maryland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30-AG021334"],"award-info":[{"award-number":["P30-AG021334"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatric.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cger.2025.12.007","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:10:37Z","timestamp":1772885437000},"page":"317-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Managing Bleeding Risk in Older Adults"],"prefix":"10.1016","volume":"42","author":[{"given":"Francisco B.","family":"Alexandrino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venu","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar","family":"Krishnaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Nanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulla A.","family":"Damluji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cger.2025.12.007_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/1524839907303794","article-title":"The economic burden of chronic cardiovascular disease for major insurers","volume":"8","author":"Trogdon","year":"2007","journal-title":"Health Promot Pract"},{"issue":"3","key":"10.1016\/j.cger.2025.12.007_bib2","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIR.0000000000001112","article-title":"Management of acute coronary syndrome in the older adult population: a scientific statement from the American heart Association","volume":"147","author":"Damluji","year":"2023","journal-title":"Circulation"},{"issue":"39","key":"10.1016\/j.cger.2025.12.007_bib3","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1093\/eurheartj\/eht356","article-title":"Cardiovascular disease in Europe: epidemiological update","volume":"34","author":"Nichols","year":"2013","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.cger.2025.12.007_bib4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jcin.2024.01.284","article-title":"Chronological vs biological age in interventional cardiology: a comprehensive approach to care for older adults: JACC family series","volume":"17","author":"Damluji","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.cger.2025.12.007_bib5","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke Statistics-2018 update: a report from the American heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cger.2025.12.007_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/07853890.2017.1382713","article-title":"Case fatality of acute coronary events is improving even among elderly patients; the FINAMI study 1995-2012","volume":"50","author":"Koukkunen","year":"2018","journal-title":"Ann Med"},{"key":"10.1016\/j.cger.2025.12.007_bib7","series-title":"Encyclopedia of cardiovascular research and medicine","first-page":"245","article-title":"Management and care of older cardiac patients","author":"Damluji","year":"2018"},{"key":"10.1016\/j.cger.2025.12.007_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke Statistics\u20142021 update","author":"Virani","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cger.2025.12.007_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"issue":"23","key":"10.1016\/j.cger.2025.12.007_bib10","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cger.2025.12.007_bib11","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cger.2025.12.007_bib12","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/j.1538-7836.2010.03986.x","article-title":"Venous thrombosis in the elderly: incidence, risk factors and risk groups","volume":"8","author":"Engbers","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cger.2025.12.007_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2021.12.011","article-title":"Pulmonary embolism: age specific temporal trends in incidence and mortality in Denmark 1999\u20132018","volume":"210","author":"Sonne-Holm","year":"2022","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.cger.2025.12.007_bib14","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0895-4356(00)00373-5","article-title":"Congestive heart failure and outpatient risk of venous thromboembolism: a retrospective, case-control study","volume":"54","author":"Howell","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"9286","key":"10.1016\/j.cger.2025.12.007_bib15","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(01)06111-6","article-title":"Approach to symptomatic coronary disease in the elderly: TIME to change","volume":"358","author":"Aronow","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cger.2025.12.007_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/pace.14178","article-title":"Representation of women, older patients, ethnic, and racial minorities in trials of atrial fibrillation","volume":"44","author":"Khan","year":"2021","journal-title":"Pacing Clin Electrophysiol"},{"issue":"24","key":"10.1016\/j.cger.2025.12.007_bib17","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.cger.2025.12.007_bib18","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.cger.2025.12.007_bib19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.cger.2025.12.007_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cger.2025.12.007_bib21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/eurheartj\/ehac515","article-title":"Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 update by the ESC Working Group on Thrombosis","volume":"44","author":"Andreotti","year":"2023","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.cger.2025.12.007_bib22","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.amjmed.2015.05.044","article-title":"National trends in ambulatory oral anticoagulant use","volume":"128","author":"Barnes","year":"2015","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.cger.2025.12.007_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10557-019-06867-z","article-title":"Examining the risks of major bleeding events in older people using antithrombotics","volume":"33","author":"Nishtala","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"issue":"8","key":"10.1016\/j.cger.2025.12.007_bib24","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1532-5415.2006.00828.x","article-title":"Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study","volume":"54","author":"Fang","year":"2006","journal-title":"J Am Geriatr Soc"},{"issue":"26","key":"10.1016\/j.cger.2025.12.007_bib25","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/eurheartj\/ehaf231","article-title":"Healthy ageing in older adults with cardiovascular disease","volume":"46","author":"Schmanske","year":"2025","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.cger.2025.12.007_bib26","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3324\/haematol.2017.182220","article-title":"A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK (ORANGE study)","volume":"103","author":"Green","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.cger.2025.12.007_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American college of Cardiology\/American Heart Association Joint Committee on clinical practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cger.2025.12.007_bib28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1055\/s-0038-1635259","article-title":"Prediction of post-discharge bleeding in elderly patients with acute coronary syndromes: insights from the BleeMACS registry","volume":"118","author":"Garay","year":"2018","journal-title":"Thromb Haemost"},{"issue":"20","key":"10.1016\/j.cger.2025.12.007_bib29","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Hijazi","year":"2016","journal-title":"Eur Heart J"},{"issue":"31","key":"10.1016\/j.cger.2025.12.007_bib30","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding risk","volume":"40","author":"Urban","year":"2019","journal-title":"Eur Heart J"},{"issue":"10073","key":"10.1016\/j.cger.2025.12.007_bib31","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cger.2025.12.007_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.cger.2025.12.007_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.semnephrol.2009.06.006","article-title":"Interaction of aging and chronic kidney disease","volume":"29","author":"Prakash","year":"2009","journal-title":"Semin Nephrol"},{"issue":"7","key":"10.1016\/j.cger.2025.12.007_bib34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.cger.2025.12.007_bib35","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1016\/j.jacc.2016.02.082","article-title":"Nonvitamin K anticoagulant agents in patients with advanced chronic kidney disease or on dialysis with AF","volume":"67","author":"Chan","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.cger.2025.12.007_bib36","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/CIRCULATIONAHA.116.024073","article-title":"Untreated hypertension: a powerful risk factor for lobar and nonlobar intracerebral hemorrhage in whites, blacks, and hispanics","volume":"134","author":"Walsh","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cger.2025.12.007_bib37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cger.2018.04.002","article-title":"Older Adult Falls in emergency Medicine-A sentinel event","volume":"34","author":"Carpenter","year":"2018","journal-title":"Clin Geriatr Med"},{"issue":"3","key":"10.1016\/j.cger.2025.12.007_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150939","article-title":"Falls and fall-related injuries among community-dwelling adults in the United States","volume":"11","author":"Verma","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cger.2025.12.007_bib39","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.amjmed.2005.02.022","article-title":"Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall","volume":"118","author":"Gage","year":"2005","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.cger.2025.12.007_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjopharm.2011.02.004","article-title":"A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity","volume":"9","author":"Gellad","year":"2011","journal-title":"Am J Geriatr Pharmacother"},{"issue":"1","key":"10.1016\/j.cger.2025.12.007_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1543-5946(04)90005-0","article-title":"A conceptual framework to study medication adherence in older adults","volume":"2","author":"Murray","year":"2004","journal-title":"Am J Geriatr Pharmacother"},{"issue":"4","key":"10.1016\/j.cger.2025.12.007_bib42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.5428\/pcar20130417","article-title":"One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events","volume":"19","author":"Chen","year":"2013","journal-title":"J Manag Care Pharm"},{"issue":"4","key":"10.1016\/j.cger.2025.12.007_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40266-014-0163-7","article-title":"Medication non-adherence among elderly patients newly discharged and receiving polypharmacy","volume":"31","author":"Pasina","year":"2014","journal-title":"Drugs Aging"},{"issue":"10452","key":"10.1016\/j.cger.2025.12.007_bib44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the lancet standing Commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cger.2025.12.007_bib45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jacc.2018.10.077","article-title":"Atrial fibrillation and cognitive function: JACC review topic of the week","volume":"73","author":"Diener","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.cger.2025.12.007_bib46","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.jacc.2025.04.057","article-title":"The impact of cognitive impairment on cardiovascular disease","volume":"85","author":"Jamil","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.cger.2025.12.007_bib47","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/01.STR.31.4.822","article-title":"Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation","volume":"31","author":"Gage","year":"2000","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.cger.2025.12.007_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2340\/165020011991193202","article-title":"Assessment of activities of daily living in the elderly. A study of a population of 76-year-olds in Gothenburg, Sweden","volume":"23","author":"Sonn","year":"1991","journal-title":"Scand J Rehabil Med"},{"key":"10.1016\/j.cger.2025.12.007_bib49","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/CIA.S159373","article-title":"Hospitalized frail elderly patients - atrial fibrillation, anticoagulation and 12 months\u2019 outcomes","volume":"13","author":"Ekerstad","year":"2018","journal-title":"Clin Interv Aging"},{"issue":"7","key":"10.1016\/j.cger.2025.12.007_bib50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archinte.159.7.677","article-title":"Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls","volume":"159","author":"Man-Son-Hing","year":"1999","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.cger.2025.12.007_bib51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jacc.2025.04.069","article-title":"Anticoagulants for atrial fibrillation in survivors of intracranial hemorrhage: a meta-analysis of randomized trials","volume":"86","author":"Chi","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.cger.2025.12.007_bib52","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jacep.2019.07.011","article-title":"Ischemic and bleeding outcomes in patients with atrial fibrillation and contraindications to oral anticoagulation","volume":"5","author":"Steinberg","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"issue":"13","key":"10.1016\/j.cger.2025.12.007_bib53","first-page":"e771","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of Cardiology\/American Heart Association Joint Committee on clinical practice Guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cger.2025.12.007_bib54","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.cger.2025.12.007_bib55","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.cger.2025.12.007_bib56","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1161\/CIRCULATIONAHA.120.050645","article-title":"Comparison between ticagrelor and clopidogrel in elderly patients with an acute coronary syndrome: insights from the SWEDEHEART registry","volume":"142","author":"Szummer","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cger.2025.12.007_bib57","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1177\/0091270011406280","article-title":"Relationship between exposure to prasugrel active metabolite and clinical outcomes in the TRITON-TIMI 38 substudy","volume":"52","author":"Riesmeyer","year":"2012","journal-title":"J Clin Pharmacol"},{"issue":"23","key":"10.1016\/j.cger.2025.12.007_bib58","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.117.032180","article-title":"Comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization","volume":"137","author":"Savonitto","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cger.2025.12.007_bib59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCULATIONAHA.120.046786","article-title":"Comparative efficacy and safety of oral P2Y12 inhibitors in acute coronary syndrome: network meta-analysis of 52 816 patients from 12 randomized trials","volume":"142","author":"Navarese","year":"2020","journal-title":"Circulation"},{"issue":"46","key":"10.1016\/j.cger.2025.12.007_bib60","first-page":"3238","article-title":"Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis","volume":"36","author":"Andreotti","year":"2015","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.cger.2025.12.007_bib61","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jcin.2023.01.366","article-title":"Abbreviated or standard antiplatelet therapy in HBR patients: final 15-Month results of the MASTER-DAPT trial","volume":"16","author":"Landi","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"10.1016\/j.cger.2025.12.007_bib62","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.cger.2025.12.007_bib63","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.cger.2025.12.007_bib64","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/CIRCULATIONAHA.119.044584","article-title":"Stent thrombosis in patients with atrial fibrillation undergoing coronary stenting in the AUGUSTUS trial","volume":"141","author":"Lopes","year":"2020","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.cger.2025.12.007_bib65","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic therapy for atrial fibrillation with stable coronary disease","volume":"381","author":"Yasuda","year":"2019","journal-title":"N Engl J Med"},{"issue":"10235","key":"10.1016\/j.cger.2025.12.007_bib66","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0140-6736(20)30315-9","article-title":"Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis","volume":"395","author":"Chiarito","year":"2020","journal-title":"Lancet"},{"issue":"10293","key":"10.1016\/j.cger.2025.12.007_bib67","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/S0140-6736(21)01063-1","article-title":"Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial","volume":"397","author":"Koo","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cger.2025.12.007_bib68","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jacc.2021.10.028","article-title":"Magnetically controlled capsule endoscopy for assessment of antiplatelet therapy-induced gastrointestinal injury","volume":"79","author":"Han","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"10093","key":"10.1016\/j.cger.2025.12.007_bib69","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(17)30770-5","article-title":"Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study","volume":"390","author":"Li","year":"2017","journal-title":"Lancet"},{"issue":"36","key":"10.1016\/j.cger.2025.12.007_bib70","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.cger.2025.12.007_bib71","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/eurheartj\/eht483","article-title":"Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke","volume":"35","author":"Piccini","year":"2014","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.cger.2025.12.007_bib72","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.amjcard.2020.02.028","article-title":"Comparing Major bleeding risk in outpatients with atrial fibrillation or flutter by oral anticoagulant type (from the national cardiovascular disease registry\u2019s practice innovation and clinical Excellence registry)","volume":"125","author":"Wong","year":"2020","journal-title":"Am J Cardiol"},{"issue":"16","key":"10.1016\/j.cger.2025.12.007_bib73","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2146\/ajhp160756","article-title":"Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation","volume":"74","author":"Alalwan","year":"2017","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"10.1016\/j.cger.2025.12.007_bib74","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008643","article-title":"Effectiveness and safety of Apixaban, Dabigatran, and rivaroxaban versus warfarin in frail patients with nonvalvular atrial fibrillation","volume":"7","author":"Martinez","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.cger.2025.12.007_bib75","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3390\/pharmaceutics14061120","article-title":"Drug-Drug interactions of direct oral anticoagulants (DOACs): from pharmacological to clinical practice","volume":"14","author":"Ferri","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.cger.2025.12.007_bib76","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European heart rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.cger.2025.12.007_bib77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijcard.2016.06.041","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"219","author":"Belgaid","year":"2016","journal-title":"Int J Cardiol"},{"issue":"23","key":"10.1016\/j.cger.2025.12.007_bib78","article-title":"Racial and ethnic disparities in the use and outcomes with WATCHMAN FLX: a SURPASS analysis of the NCDR left atrial appendage occlusion registry","volume":"13","author":"Alli","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.cger.2025.12.007_bib80","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.chest.2024.03.003","article-title":"Antithrombotic therapy for VTE disease: Compendium and Review of CHEST Guidelines 2012-2021","volume":"166","author":"Stevens","year":"2024","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.cger.2025.12.007_bib81","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.cger.2025.12.007_bib82","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman","year":"2014","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.cger.2025.12.007_bib83","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"B\u00fcller","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.cger.2025.12.007_bib84","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.cger.2025.12.007_bib85","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"B\u00fcller","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cger.2025.12.007_bib86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-9560-12-21","article-title":"Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulants","volume":"12","author":"Geldhof","year":"2014","journal-title":"Thromb J"},{"issue":"13","key":"10.1016\/j.cger.2025.12.007_bib87","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMe1701628","article-title":"Reduced-Intensity rivaroxaban for the prevention of recurrent venous thromboembolism","volume":"376","author":"Crowther","year":"2017","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.cger.2025.12.007_bib88","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cger.2025.12.007_bib89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.thromres.2023.06.027","article-title":"Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: a systematic review and meta-analysis","volume":"229","author":"Almajdi","year":"2023","journal-title":"Thromb Res"},{"issue":"14","key":"10.1016\/j.cger.2025.12.007_bib90","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.cger.2025.12.007_bib91","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ejcts\/ezx314","article-title":"2017 EACTS Guidelines on perioperative medication in adult cardiac surgery","volume":"53","author":"Sousa-Uva","year":"2018","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"35","key":"10.1016\/j.cger.2025.12.007_bib92","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu285","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.cger.2025.12.007_bib93","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood-2019-01-846048","article-title":"How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism","volume":"133","author":"Chan","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cger.2025.12.007_bib94","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.cger.2025.12.007_bib95","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/hematology.2024000666","article-title":"DOACs: role of anti-Xa and drug level monitoring","volume":"2024","author":"Mithoowani","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.cger.2025.12.007_bib96","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.thromres.2015.12.001","article-title":"Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: results observed in four anticoagulation clinics","volume":"137","author":"Testa","year":"2016","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.cger.2025.12.007_bib97","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jamacardio.2017.0364","article-title":"Laboratory monitoring of non-vitamin K antagonist oral anticoagulant use in patients with atrial fibrillation: a review","volume":"2","author":"Eikelboom","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"1\u20132","key":"10.1016\/j.cger.2025.12.007_bib98","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000502335","article-title":"Direct oral anticoagulant plasma levels for the management of Acute Ischemic stroke","volume":"48","author":"Marsch","year":"2019","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.cger.2025.12.007_bib99","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"19","key":"10.1016\/j.cger.2025.12.007_bib100","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1001\/jama.2016.9185","article-title":"Clinical Practice Guidelines from the AABB: red blood cell transfusion thresholds and storage","volume":"316","author":"Carson","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.cger.2025.12.007_bib101","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1111\/trf.13735","article-title":"Red blood cell transfusion: 2016 clinical practice guidelines from AABB","volume":"56","author":"Tobian","year":"2016","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.cger.2025.12.007_bib102","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.113.002283","article-title":"Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study","volume":"128","author":"Sarode","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cger.2025.12.007_bib103","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacc.2020.04.053","article-title":"2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants","volume":"76","author":"Tomaselli","year":"2020","journal-title":"JACC"},{"issue":"8","key":"10.1016\/j.cger.2025.12.007_bib104","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cger.2025.12.007_bib105","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.cger.2025.12.007_bib106","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199802123380701","article-title":"A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Pr\u00e9vention du Risque d\u2019Embolie Pulmonaire par Interruption Cave Study Group","volume":"338","author":"Decousus","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cger.2025.12.007_bib107","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2019.01.020","article-title":"Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: a systematic review and meta-analysis","volume":"175","author":"Little","year":"2019","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.cger.2025.12.007_bib108","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamaneurol.2025.0026","article-title":"Location and timing of recurrent, nontraumatic intracerebral hemorrhage","volume":"82","author":"Goeldlin","year":"2025","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.cger.2025.12.007_bib109","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a Guideline for healthcare professionals from the American heart Association\/American Stroke Association","volume":"46","author":"Hemphill","year":"2015","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.cger.2025.12.007_bib110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50963","article-title":"Cumulative update of a systematic overview evaluating interventions addressing polypharmacy","volume":"7","author":"Keller","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"20","key":"10.1016\/j.cger.2025.12.007_bib111","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2019.03.467","article-title":"Deprescribing in older adults with cardiovascular disease","volume":"73","author":"Krishnaswami","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.cger.2025.12.007_bib112","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.cger.2025.12.007_bib113","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIR.0000000000000183","article-title":"Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome","volume":"131","author":"Washam","year":"2015","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.cger.2025.12.007_bib114","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"10.1016\/j.cger.2025.12.007_bib115","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jacc.2021.11.029","article-title":"Interventions for frailty among older adults with cardiovascular disease: JACC state-of-the-art review","volume":"79","author":"Ijaz","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.cger.2025.12.007_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100318","article-title":"Hierarchical development of physical frailty and cognitive impairment and their Association with incident cardiovascular disease","volume":"2","author":"Damluji","year":"2023","journal-title":"JACC Adv"},{"issue":"37","key":"10.1016\/j.cger.2025.12.007_bib117","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1093\/eurheartj\/ehab468","article-title":"Frailty and cardiovascular outcomes in the National Health and Aging Trends Study","volume":"42","author":"Damluji","year":"2021","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.cger.2025.12.007_bib118","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.7326\/M20-7141","article-title":"Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation","volume":"174","author":"Kim","year":"2021","journal-title":"Ann Intern Med"},{"issue":"20","key":"10.1016\/j.cger.2025.12.007_bib119","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1161\/CIRCULATIONAHA.123.064071","article-title":"Sarcopenia and cardiovascular diseases","volume":"147","author":"Damluji","year":"2023","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cger.2025.12.007_bib120","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.3390\/jcm9103121","article-title":"Sarcopenia Index as a predictor of clinical outcomes in older patients with coronary artery disease","volume":"9","author":"Lee","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.cger.2025.12.007_bib121","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.2024.4166","article-title":"Interventions to prevent Falls in older adults: updated evidence report and systematic review for the US preventive services task force","volume":"332","author":"Guirguis-Blake","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.cger.2025.12.007_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M19-3671","article-title":"Association between treatment with Apixaban, Dabigatran, rivaroxaban, or warfarin and risk for osteoporotic fractures among patients with atrial fibrillation: a population-based cohort Study","volume":"173","author":"Lau","year":"2020","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.cger.2025.12.007_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100389","article-title":"Assessment and management of older adults undergoing PCI, part 1: a JACC: advances expert Panel","volume":"2","author":"Nanna","year":"2023","journal-title":"JACC Adv"},{"issue":"5","key":"10.1016\/j.cger.2025.12.007_bib124","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2174\/0929867324666170718124742","article-title":"Biomarkers associated with bleeding risk in the setting of atrial fibrillation","volume":"26","author":"Sideris","year":"2019","journal-title":"Curr Med Chem"},{"issue":"16","key":"10.1016\/j.cger.2025.12.007_bib125","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jacc.2018.07.079","article-title":"Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention","volume":"72","author":"Inouye","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"9750","key":"10.1016\/j.cger.2025.12.007_bib126","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(10)61267-6","article-title":"A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses","volume":"376","author":"Ripatti","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.cger.2025.12.007_bib127","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jama.2023.13258","article-title":"Evaluation of large-scale proteomics for prediction of cardiovascular events","volume":"330","author":"Helgason","year":"2023","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.cger.2025.12.007_bib128","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1111\/jth.15498","article-title":"Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation","volume":"19","author":"Siegbahn","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cger.2025.12.007_bib129","doi-asserted-by":"crossref","DOI":"10.2196\/65010","article-title":"Smartphone app for improving self-awareness of adherence to edoxaban treatment in patients with atrial fibrillation (ADHERE-App trial): randomized controlled trial","volume":"26","author":"Yoon","year":"2024","journal-title":"J Med Internet Res"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069025001193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069025001193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:42:59Z","timestamp":1779226979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749069025001193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0749069025001193"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2025.12.007","relation":{},"ISSN":["0749-0690"],"issn-type":[{"value":"0749-0690","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing Bleeding Risk in Older Adults","name":"articletitle","label":"Article Title"},{"value":"Clinics in Geriatric Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cger.2025.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}